Key facts
- This page summarizes Raymond W. Cohen's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jul 2021, 20:00.
Raymond W. Cohen - 12 Jul 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Reporting relationship
- Director
- Issuer ticker
- BLFS
- Reported as of
- 12 Jul 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Jul 2021, 20:00:56 UTC
- Prior SEC filing
- 10 Jun 2021
- Next SEC filing
- 13 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Raymond W. Cohen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Raymond W. Cohen filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 14 Jul 2021.
Change
- Previous filing in this sequence was filed on 10 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLFS
transaction
Common Stock
Award
- Transaction value
- Shares
- +5,000
- Change %
- +22%
- Price
- Shares after
- 27,763
- Date
- 12 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan.